Latin America point of care infectious disease market is projected to register a CAGR of 8.3% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Latin America Point of Care Infectious Disease Market By Type (Products and Services), Technology (Immunodiagnostics, Molecular Diagnostics, Dipsticks, Microfluidics and Others), Application (Tropical Diseases, Sexually Transmitted Disease, Respiratory Disorders, Liver Disorders, Inflammatory Diseases, Hospital Acquired Infections (HAIS), GI Infections, CNS Infections, Cardiovascular Infection and Others), Availability (Over-the-Counter (OTC) Testing Kits and Prescription-Based Testing Kits), End Users (Homecare Setting, Hospitals, Diagnostic Centers, Outpatient Healthcare Setting and Others),Distribution Channel (Direct Tenders and Retail Sales) Country ( Brazil, Mexico, Chile, Equador, Colombia, Argentina, Peru and Rest Of Latin America), Market Trends and Forecast to 2027
Some of the major factors contributing to the growth of the Latin America point of care infectious disease market are:

• Increasing prevalence of infectious diseases
• Need for reduction of antibiotic misuse
• Technological advancements in POCT devices

Market Players:

The key market players for Latin America point of care infectious disease market are listed below:

• Abbott
• BD
• BioMérieux SA
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Chembio Diagnostic Systems, Inc.
• Cardinal health
• Koninklijke Philips N.V.
• Thermo Fisher Scientific, Inc.